Dietary manipulation of platelet function

Pharmacol Ther. 2014 Nov;144(2):97-113. doi: 10.1016/j.pharmthera.2014.05.008. Epub 2014 May 21.

Abstract

Activated platelets contribute to plaque formation within blood vessels in the early and late stages of atherogenesis, and therefore they have been proposed as risk factor for cardiovascular disease. Anti-platelet drugs, such as aspirin, are now the most prescribed pharmacological treatment in Europe. Certain dietary bioactives also beneficially affect platelet function, and with less side effects, albeit that effects are generally more subtle. Therefore, consumption of dietary bioactives could play a role in the prevention of atherothrombotic vascular disease. Here we review the efficacy of dietary treatment strategies, especially those involving certain dietary fatty acids and polyphenols, to modulate platelet function in healthy subjects or in patients with cardiovascular disease. Variation in study populations, small study sizes and lack of comparability between methods to assess platelet function currently limit robust evidence on the efficacy of dietary bioactives in healthy subjects or specific patient groups. Also, limited knowledge of the metabolism of dietary bioactives, and therefore of the bioavailability of bioactive ingredients, restricts our ability to identify the most effective dietary regimes to improve platelet function. Implementation of uniform point-of-care tests to assess platelet function, and enhanced knowledge of the efficacy by which specific dietary compounds and their metabolites affect platelet function, may enable the identification of functional anti-platelet ingredients that are eligible for a health claim, or combined treatment strategies, including both pharmacological anti-platelet treatment as well as dietary intervention, to tackle atherothrombotic vascular disease.

Keywords: Cardiovascular disease; Diet; Dietary fatty acids; Dietary polyphenols; Platelet function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Atherosclerosis / physiopathology
  • Blood Platelets / metabolism*
  • Diet*
  • Docosahexaenoic Acids / pharmacology*
  • Eicosapentaenoic Acid / pharmacology*
  • Flavonoids / pharmacology
  • Humans
  • Inflammation / physiopathology
  • Plaque, Atherosclerotic / physiopathology
  • Platelet Activation / physiology
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Function Tests
  • Polyphenols / pharmacology
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Sex Factors

Substances

  • Flavonoids
  • Platelet Aggregation Inhibitors
  • Polyphenols
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid